CC
ASMB icon

Caxton Corporation’s Assembly Biosciences ASMB Stock Holding History

Caxton Corporation’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,385
Closed -$340K – 19
2019
Q4 		$340K Buy
+1,385
New +$255K 0.33% 16
2016
Q2 		– Sell
-1,849
Closed -$111K – 17
2016
Q1 		$111K Buy
1,849
+341
+23% +$22.8K 0.15% 17
2015
Q4 		$136K Buy
+1,508
New +$164K 0.57% 16

Other funds holding ASMB

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Caxton Corporation's ASMB Position: Q1 2020 in Review

Caxton Corporation sold out of Assembly Biosciences (ASMB) in Q1 2020, closing a stake of 1,385 shares — an estimated $340K sold.

Caxton Corporation first reported a position in ASMB in Q4 2015 and held it in 3 quarters. The position peaked at $340K in Q4 2019. 98 funds tracked by Wall St. Rank hold ASMB as of Q1 2020.

  • Caxton Corporation reported no remaining Assembly Biosciences position as of Q1 2020 after selling out during the quarter.
  • Caxton Corporation sold 1,385 Assembly Biosciences shares in Q1 2020, an estimated $340K.
  • Caxton Corporation first reported a position in Assembly Biosciences in Q4 2015 and held it in 3 quarters.
  • Caxton Corporation's Assembly Biosciences position peaked at $340K in Q4 2019.
  • 98 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2020.

Based on Caxton Corporation's 13F filing for Q1 2020, filed 15 May 2020.